Scholar Rock Holding Corporation (SRRK)
- Business Wire
Scholar Rock to Host Investor Day on May 22, 2024
CAMBRIDGE, Mass., May 14, 2024--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced it will host an Investor Day on Wednesday, May 22, 2024 beginning at 8:30 a.m. ET in New York City.
- GuruFocus.com
Scholar Rock Holding Corp (SRRK) Reports Q1 2024 Financial Results: A Detailed Analysis
Exploring the Financial Landscape and Strategic Progress Amidst Challenges
- Business Wire
Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress
CAMBRIDGE, Mass., May 07, 2024--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today reported financial results and corporate updates for the first quarter ended March 31, 2024.
